People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adicet Bio, Inc. | — | Biotechnology | Series C | $116.8M | $3.3B | 2015 |
Anne Altmeyer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anne Altmeyer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| Asish Xavier | 1 | 18 |
| Jonathan Silverstein | 1 | 10 |
| Michal Silverberg | 1 | 7 |
| Erez Chimovits | 1 | 7 |
| Yair Schindel | 1 | 4 |
| Florent Gros | 1 | 4 |
| Donald Santel | 1 | 4 |
| Brian Hogan | 1 | 4 |
| Nathan Hubbard | 1 | 3 |
| Aya Jakobovits | 1 | 2 |
| Steward Abbot | 1 | 1 |
| Francesco Galini | 1 | 1 |
| Carrie Krehlik | 1 | 1 |
| Stewart Abbot | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.